The Department of Health and Human Services (HHS) will collaborate with Regeneron Pharmaceuticals to develop new treatments to combat the Novel Coronavirus, 2019-nCoV, it announced on Feb. 4.
The New York-based biotechnology company Regeneron Pharmaceuticals will work in partnership with the department to develop “multiple monoclonal antibodies” that could be used individually or in combination to treat the virus, according to a press statement.
